Table 3.
Percentage of positive anti-caspase 3 reaction | Control (n = 5) | Cisplatin treated (n = 5) | PRP treated (n = 5) | F | p |
---|---|---|---|---|---|
Min.–Max. | 2.04–3.17 | 25.10–32.76 | 7.70–9.70 | 319.551* | <0.001* |
Mean ± SD. | 2.49 ± 0.48 | 29.04 ± 2.84 | 8.95 ± 0.85 | ||
Median | 2.43 | 29.17 | 9.20 | ||
p1 | <0.001* | <0.001* | |||
p2 | <0.001* |
SD, standard deviation
F, F for one-way ANOVA test, Pairwise comparison bet. each 2 groups was done using post hoc test (Tukey)
p, p value for comparing between the three studied groups
p1, p value for comparing between control and each other group
p2, p value for comparing between cisplatin treated and PRP treated
*Statistically significant at p ≤ 0.05